Virtus ETF Advisers’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,434
| Closed | -$68.1K | – | 544 |
|
|
2024
Q4 | $68.1K | Sell |
8,434
-3,563
| -30% | -$28.8K | 0.03% | 395 |
|
|
2024
Q3 | $123K | Buy |
11,997
+210
| +2% | +$2.15K | 0.06% | 349 |
|
|
2024
Q2 | $83.3K | Buy |
11,787
+2,350
| +25% | +$16.6K | 0.04% | 389 |
|
|
2024
Q1 | $130K | Sell |
9,437
-648
| -6% | -$8.91K | 0.07% | 341 |
|
|
2023
Q4 | $92.8K | Buy |
+10,085
| New | +$92.8K | 0.06% | 392 |
|
|
2022
Q2 | – | Sell |
-12,914
| Closed | -$69K | – | 463 |
|
|
2022
Q1 | $69K | Sell |
12,914
-763
| -6% | -$4.08K | 0.03% | 353 |
|
|
2021
Q4 | $201K | Buy |
13,677
+2,895
| +27% | +$42.5K | 0.08% | 207 |
|
|
2021
Q3 | $225K | Sell |
10,782
-567
| -5% | -$11.8K | 0.1% | 240 |
|
|
2021
Q2 | $201K | Buy |
11,349
+2,955
| +35% | +$52.3K | 0.08% | 343 |
|
|
2021
Q1 | $206K | Buy |
8,394
+147
| +2% | +$3.61K | 0.09% | 324 |
|
|
2020
Q4 | $279K | Buy |
+8,247
| New | +$279K | 0.12% | 248 |
|